NICE is minded not to recommend dapagliflozin (Forxiga, Brstol-Myers Squibb and Astra Zeneca) in combination therapy for treating type 2 diabetes. NICE is requesting further clarification and information from the manufacturers ahead of the second Appraisal Committee meeting in March (NICE)
Diabetes News Service
Glycosmedia is also available as an App:
For iPhone and iPad | For Android devices
Sponsorship and Advertising
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
